India’s radiopharmaceuticals market is expanding as cancer incidence, chronic disease diagnosis, and investment in nuclear medicine increase. The market was valued at USD 0.44 billion in 2024 and is projected to reach USD 1.06 billion by 2035, reflecting an estimated CAGR of 8.26%. 1087 Radiopharmaceuticals are radioactive compounds used in specialized diagnostic imaging and therapeutic...